Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Egetis Therapeutics - Filing #701621

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	416 366 SEK	—	—	—	—	—	—	—	417 130 SEK	—	—	—
Current assets	152 902 SEK	—	—	—	—	—	—	—	299 871 SEK	—	—	—
Non-current liabilities	3 060 SEK	—	—	—	—	—	—	—	16 135 SEK	—	—	—
Current liabilities	39 170 SEK	—	—	—	—	—	—	—	70 141 SEK	—	—	—
Revenue	—	—	—	—	38 243 SEK	—	—	—	—	40 662 SEK	—	—
Profit (loss)	—	—	—	—	104 542 SEK	—	—	—	—	178 024 SEK	—	—
Other comprehensive income	—	—	—	—	- SEK	—	—	—	—	- SEK	—	—
Comprehensive income	—	– SEK	– SEK	– SEK	104 542 SEK	104 542 SEK	178 024 SEK	– SEK	—	178 024 SEK	– SEK	– SEK